Liukun Meng

407 citations
22 papers · 283 indexed · h-index 11
Topics
Pulmonary Hypertension Research and Treatments (11 papers)Congenital Heart Disease Studies (7 papers)Cardiomyopathy and Myosin Studies (5 papers)

In The Last Decade

Liukun Meng

22 papers receiving 280 citations

Peers

Liukun Meng
Comparison fields: 5 of 65
  • Pulmonary and Respiratory Medicine 139
  • Molecular Biology 89
  • Cardiology and Cardiovascular Medicine 83
  • Surgery 48
  • Epidemiology 42
Replace Rika Suda with:
Rika Suda Japan
Kenta Uto Japan
Kanji Minamoto Japan
Donato Moschetta Italy
Karl‐Otto Larsen Norway
Ayumi Sekine Japan
Daihiko Eguchi Japan
Antonia Serio Italy
Jason B. Wheeler United States
Alicia Gainza Spain
Liukun Meng relative to Rika Suda Japan Rika Suda's profile →
Citations per field
00.5×1.5×
Rika Suda · 1×
Citations per year

Countries citing papers authored by Liukun Meng

Since Specialization
Citations

This map shows the geographic impact of Liukun Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liukun Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liukun Meng more than expected).

Fields of papers citing papers by Liukun Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liukun Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liukun Meng. The network helps show where Liukun Meng may publish in the future.

Co-authorship network of co-authors of Liukun Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Liukun Meng. A scholar is included among the top collaborators of Liukun Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liukun Meng. Liukun Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 1
3 3
4 4
5 3
6 4
7 13
8 5
9 4
10 7
11 5
12 21
13 34
14 13
15 16
16 28
17 29
18 18
19 28
20 2

About Liukun Meng

Liukun Meng is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 22 papers that have together received 283 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (11 papers), Congenital Heart Disease Studies (7 papers) and Cardiomyopathy and Myosin Studies (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (139 citations), Cardiology and Cardiovascular Medicine (83 citations) and Nephrology (16 citations). Liukun Meng has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Yingjie Wei, Xiaoyan Liu, Chuan-Jue Cui, Shengshou Hu, Guoliang Wang, Ning Ma, Jingang Gui, Jianping Meng, Shengshou Hu and Shengwei Wang. Their work appears in journals such as The FASEB Journal, Nutrients and Journal of Thoracic and Cardiovascular Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026